Results 81 to 90 of about 5,563 (197)

Novel Nonsense Mutation in SMARCD2 Gene Results in Dysplasia of All Myeloid Cell Lines

open access: yeseJHaem, Volume 6, Issue 6, December 2025.
ABSTRACT Introduction Specific granule deficiency type II (SGD2) is a rare heterogeneous congenital disease characterized by early‐onset life‐threatening infections. SGD2 is caused by autosomal recessive mutations in the SMARCD2 gene. Methods Prenatal screening in our patient revealed a novel homozygous nonsense mutation in SMARCD2 (c.208C>T, p.Gln70*).
Michelle A. E. Brouwer   +6 more
wiley   +1 more source

Mitochondrial Dysfunction Induced by a Novel Salicylate‐Based 1,2,3‐Triazole Salt With Potent Antileishmanial Activity

open access: yesChemical Biology &Drug Design, Volume 106, Issue 6, December 2025.
A novel salicylate‐based 1,2,3‐triazole salt was synthesized and demonstrated potent and selective activity against Leishmania amazonensis. The most active compound induced mitochondrial dysfunction without hemolytic effects. In silico analyses also suggested favorable pharmacokinetic properties and oral bioavailability.
Bruno A. De Oliveira   +8 more
wiley   +1 more source

First molecular-based detection of mucocutaneous leishmaniasis caused by Leishmania major in Iran

open access: yesJournal of Infection in Developing Countries, 2013
Mucocutaneous leishmaniasis, which mostly occurs in the New World, is mainly associated with Leishmania braziliensis and to a lesser degree L. panamensis and L. amazonensis infections.
Abdolvahab Alborzi   +6 more
doaj   +1 more source

Mapping the Burden of Tegumentary Leishmaniasis in South America: A Systematic Review and Meta‐Analysis

open access: yesTropical Medicine &International Health, Volume 30, Issue 12, Page 1261-1268, December 2025.
ABSTRACT Introduction In recent years, the global burden of tegumentary leishmaniasis (TL) has significantly increased in the Americas. Objective To estimate the prevalence of TL in South America based on publications from the past 13 years. Methods Three databases were searched, and articles were selected based on inclusion criteria and methodological
Sérgio Caldas   +4 more
wiley   +1 more source

The accuracy of the Montenegro skin test for leishmaniasis in PCR-negative patients

open access: yesRevista da Sociedade Brasileira de Medicina Tropical, 2020
INTRODUCTION: As highly specific molecular biology-based techniques may not be sensitive enough for the diagnosis of American tegumentary leishmaniasis (ATL), clinicians frequently rely on immunological tests before treatment initiation.
Ana Bárbara Sapienza Pinheiro   +9 more
doaj   +1 more source

Cerebral Complication of Cutaneous Leishmaniasis: about a case

open access: yesJournal de la Faculté de Médecine d'Oran, 2022
Leishmaniasis (L) is a cutaneous, mucocutaneous, or visceral disease caused by intracellular Leishmania protozoan parasites that are transmitted by the bite of female sand flies.
Schahrazed Linda MAGUENOUCHE   +2 more
doaj  

Dermatologic and otorhinolaryngologic manifestations in leishmaniasis

open access: yesInternational Archives of Otorhinolaryngology, 2011
Introduction: Leishmaniasis is an extremely important parasitic disease as regards epidemiology, and, in such a disease, man is an occasional host to the Leishmania protozoon.
Mota, Luiz Alberto Alves   +1 more
doaj  

Leishmaniasis in humans and small animals: Updates and insights through a one health

open access: yesLetters in Animal Biology
Leishmaniasis is neglected infectious disease caused by a type of microscopic parasite called Leishmania spp. This disease can affect both humans and animals, as well as sandflies.
Amirhossein Badkoubi   +6 more
doaj   +1 more source

Home - About - Disclaimer - Privacy